MaassenVanDenBrink A - Search Results

1

Characterisation of vasodilatory responses in the presence of the CGRP receptor antibody erenumab in human isolated arteries.

Rubio-Beltrán E, Labastida-Ramírez A, Haanes KA, van den Bogaerdt A, Bogers AJ, Dirven C, Danser AJ, Xu C, Snellman J, MaassenVanDenBrink A. Rubio-Beltrán E, et al. Among authors: maassenvandenbrink a. Cephalalgia. 2019 Dec;39(14):1735-1744. doi: 10.1177/0333102419863027. Epub 2019 Jul 8. Cephalalgia. 2019. PMID: 31284729

2

5-HT1B receptor polymorphism and clinical response to sumatriptan.

MaassenVanDenBrink A, Vergouwe MN, Ophoff RA, Saxena PR, Ferrari MD, Frants RR. MaassenVanDenBrink A, et al. Headache. 1998 Apr;38(4):288-91. doi: 10.1046/j.1526-4610.1998.3804288.x. Headache. 1998. PMID: 9595868

3

Human isolated coronary artery contraction to sumatriptan: a post hoc analysis.

Maassen VanDenBrink A, Bax WA, Ramrattan NN, Ferrari MD, Saxena PR. Maassen VanDenBrink A, et al. Cephalalgia. 1999 Sep;19(7):651-4. doi: 10.1046/j.1468-2982.1999.019007651.x. Cephalalgia. 1999. PMID: 10524658

4

Pharmacological analysis of contractile effects of eletriptan and sumatriptan on human isolated blood vessels.

van den Broek RW, MaassenVanDenBrink A, de Vries R, Bogers AJ, Stegmann AP, Avezaat CJ, Saxena PR. van den Broek RW, et al. Among authors: maassenvandenbrink a. Eur J Pharmacol. 2000 Oct 27;407(1-2):165-73. doi: 10.1016/s0014-2999(00)00712-3. Eur J Pharmacol. 2000. PMID: 11050304

5

The potential anti-migraine compound SB-220453 does not contract human isolated blood vessels or myocardium; a comparison with sumatriptan.

MaassenVanDenBrink A, van den Broek RW, de Vries R, Upton N, Parsons AA, Saxena PR. MaassenVanDenBrink A, et al. Cephalalgia. 2000 Jul;20(6):538-45. doi: 10.1046/j.1468-2982.2000.00078.x. Cephalalgia. 2000. PMID: 11075836

6

Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels.

MaassenVanDenBrink A, van den Broek RW, de Vries R, Bogers AJ, Avezaat CJ, Saxena PR. MaassenVanDenBrink A, et al. Neurology. 2000 Nov 28;55(10):1524-30. doi: 10.1212/wnl.55.10.1524. Neurology. 2000. PMID: 11094108

7

Comparison of contractile responses to donitriptan and sumatriptan in the human middle meningeal and coronary arteries.

van den Broek RW, MaassenVanDenBrink A, Mulder PG, Bogers AJ, Avezaat CJ, John GW, Saxena PR. van den Broek RW, et al. Among authors: maassenvandenbrink a. Eur J Pharmacol. 2002 May 17;443(1-3):125-32. doi: 10.1016/s0014-2999(02)01576-5. Eur J Pharmacol. 2002. PMID: 12044802

8

Coronary vasoconstrictor potential of triptans: a review of in vitro pharmacologic data.

Maassen Van Den Brink A, Saxena PR. Maassen Van Den Brink A, et al. Headache. 2004 May;44 Suppl 1:S13-9. doi: 10.1111/j.1526-4610.2004.04104.x. Headache. 2004. PMID: 15149489 Review.

9

Assessment of anti-migraine potential of a novel alpha-adrenoceptor agonist S19014: effects on porcine carotid and regional haemodynamics and human coronary artery.

Kapoor K, Willems EW, Maassen VanDenBrink A, Heiligers JP, Cordi AA, Vayssettes-Courchay C, Verbeuren TJ, Villalón CM, Saxena PR. Kapoor K, et al. Cephalalgia. 2004 Jun;24(6):425-38. doi: 10.1111/j.1468-2982.2004.00684.x. Cephalalgia. 2004. PMID: 15154852

10

Characterisation of CGRP receptors in human and porcine isolated coronary arteries: evidence for CGRP receptor heterogeneity.

Gupta S, Mehrotra S, Villalón CM, Garrelds IM, de Vries R, van Kats JP, Sharma HS, Saxena PR, Maassenvandenbrink A. Gupta S, et al. Among authors: maassenvandenbrink a. Eur J Pharmacol. 2006 Jan 13;530(1-2):107-16. doi: 10.1016/j.ejphar.2005.11.020. Epub 2005 Dec 22. Eur J Pharmacol. 2006. PMID: 16375887

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters